Back
Poseida Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
48
PSTX
Poseida Therapeutics
Last Price:
$9.50
Seasonality Move:
-14.94%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Poseida Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.48 | Buy |
| 20-day SMA: | 9.43 | Buy |
| 50-day SMA: | 5.54 | Buy |
| 200-day SMA: | 3.57 | Buy |
| 8-day EMA: | 9.44 | Buy |
| 20-day EMA: | 8.65 | Buy |
| 50-day EMA: | 6.58 | Buy |
| 200-day EMA: | 4.14 | Buy |
Poseida Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 86.4 | Buy |
| Chaikin Money Flow: | 503879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.91 - 10.81) | Buy |
| Bollinger Bands (100): | (1.51 - 6.91) | Buy |
Poseida Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Poseida Therapeutics Stock
Is Poseida Therapeutics Stock a Buy?
-
Poseida Therapeutics share price is 9.51 while PSTX 8-day simple moving average is 9.48, which is a Buy signal.
-
The stock price of PSTX is 9.51 while Poseida Therapeutics 20-day SMA is 9.43, which makes it a Buy.
-
Poseida Therapeutics 50-day simple moving average is 5.54 while PSTX share price is 9.51, making it a Buy technically.
-
PSTX stock price is 9.51 and Poseida Therapeutics 200-day simple moving average is 3.57, creating a Buy signal.
PSTX Technical Analysis vs Fundamental Analysis
Sell
48
Poseida Therapeutics (PSTX)
is a Sell
Is Poseida Therapeutics a Buy or a Sell?
-
Poseida Therapeutics stock is rated a SellThe current Poseida Therapeutics [PSTX] share price is $9.51. The Score for PSTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Poseida Therapeutics Stock Info
Market Cap:
926.9M
Price in USD:
9.51
Share Volume:
647.8K
Poseida Therapeutics 52-Week Range
52-Week High:
9.58
52-Week Low:
1.87
Sell
48
Poseida Therapeutics (PSTX)
is a Sell
Poseida Therapeutics Share Price Forecast
-
What is the Poseida Therapeutics stock price today?The Poseida Therapeutics stock price is 9.51 USD today.
-
Will PSTX stock go up or go down?Poseida Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Poseida Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Poseida Therapeutics is overvalued.
Is Poseida Therapeutics Stock a Buy?
-
Poseida Therapeutics share price is 9.51 while PSTX 8-day exponential moving average is 9.44, which is a Buy signal.
-
The stock price of PSTX is 9.51 while Poseida Therapeutics 20-day EMA is 8.65, which makes it a Buy.
-
Poseida Therapeutics 50-day exponential moving average is 6.58 while PSTX share price is 9.51, making it a Buy technically.
-
PSTX stock price is 9.51 and Poseida Therapeutics 200-day simple moving average is 4.14, creating a Buy signal.
Fundamental Analysis of Poseida Therapeutics
Is Poseida Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $1.08 per share.
Technical Analysis of Poseida Therapeutics
Should I short Poseida Therapeutics stock?
-
PSTX Moving Average Covergence Divergence (MACD) indicator is 1.14, suggesting Poseida Therapeutics is a Buy
-
Poseida Therapeutics Relative Strength Index (RSI) is 86.4, which suggest Poseida Therapeutics is overbought
-
The Bollinger Bands (25) for Poseida Therapeutics is (5.91 - 10.81), which suggest Poseida Therapeutics is a Buy
-
The Bollinger Bands (100) for Poseida Therapeutics is (1.51 - 6.91), which suggest Poseida Therapeutics is a Buy
* Poseida Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.